QQ客服 官方微博 反馈留言

	Transcriptomic analyses identify key differentially expressed genes and clinical outcomes between triple-negative and non-triple-negative breast cancer
	Chen, Bo; Tang, Hailin; Chen, Xi; Zhang, Guochun; Wang, Yulei; Xie, Xiaoming*; Liao, Ning*
刊名	Cancer Management and Research
	2019
卷号	11页码:179-190
关键词	HORMAD1 non-triple-negative breast cancer prognostic factor transcriptome triple-negative breast cancer
ISSN号	1179-1322
DOI	10.2147/CMAR.S187151
URL标识	查看原文
WOS记录号	WOS:000454525200002
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/5677829
专题	南华大学
作者单位	1.[Liao, Ning 2.Zhang, Guochun 3.Wang, Yulei 4.Chen, Bo] Guangdong Gen Hosp, Dept Breast Canc, Canc Ctr, 106 Zhongshan 2 Rd, Guangzhou 510080, Guangdong, Peoples R China.
推荐引用方式 GB/T 7714	Chen, Bo,Tang, Hailin,Chen, Xi,et al. Transcriptomic analyses identify key differentially expressed genes and clinical outcomes between triple-negative and non-triple-negative breast cancer[J]. Cancer Management and Research,2019,11:179-190.
APA	Chen, Bo.,Tang, Hailin.,Chen, Xi.,Zhang, Guochun.,Wang, Yulei.,...&Liao, Ning*.(2019).Transcriptomic analyses identify key differentially expressed genes and clinical outcomes between triple-negative and non-triple-negative breast cancer.Cancer Management and Research,11,179-190.
MLA	Chen, Bo,et al."Transcriptomic analyses identify key differentially expressed genes and clinical outcomes between triple-negative and non-triple-negative breast cancer".Cancer Management and Research 11(2019):179-190.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。